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Abstract: A series of (3–13)-monohydroxyeicosanoic acid isomers were eva-
luated for their anti-elastase, anti-urease and antioxidant activities for the first 
time in this study. All the test compounds exhibited anti-elastase, anti-urease 
and antioxidant activities. According to the obtained results, the hydroxyeico-
sanoic acid isomers in which the hydroxyl group is located in the middle or 
close to the middle of the chain showed higher anti-elastase, anti-urease and 
antioxidant activities than that of the other isomers. Therefore, (3–13)-mono-
hydroxyeicosanoic acid isomers can be used in agriculture, pharmacy and cos-
metic industries due to their excellent anti-elastase, anti-urease and antioxidant 
activities. 
Keywords: anti-elastase; anti-urease; antioxidant; hydroxyeicosanoic acid; en-
zyme; inhibition. 
INTRODUCTION 
Elastases are a group of serine proteases that possess the ability to cleave the 
important connective tissue protein elastin, which is widely distributed in verte-
brate tissues, and is particularly abundant in the lung, arteries, skin, and liga-
ments. These proteases include the neutrophile elastase (NE), also known as leu-
kocyte elastase, the pancreatic elastase (PE), the macrophage elastase (NMP-12) 
and the fibroblast elastase.1–3 There has been increasing interest in elastases in 
recent years because of their possible involvement in diseases of the connective 
tissues.4 Elastase activity increases significantly with age and results in reduced 
skin elastic properties, aging and sagging.5 Inhibition of the elastase activity could 
be employed as a useful target to protect against skin aging.6  
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The metalloenzyme urease (urea amidohydrolase; EC 3.5.1.5) catalyzes the 
hydrolysis of urea into ammonia and carbon dioxide. It is present in a variety of 
plants, algae, fungi, bacteria and in soil enzymes.7 Urease is involved in the pa-
thogenesis of hepatic encephalopathy, hepatic coma urolithiasis, pyelonephritis, 
ammonia and urinary catheter encrustation.8 It is also a major cause of patho-
logies induced by Helicobacter pylori (HP) as this allows bacteria to survive at 
the low pH of the stomach and hence plays an important role in producing peptic 
and gastric ulcers.9 In agriculture, high urease activity releases abnormally large 
amounts of ammonia into the atmosphere after urea application and causes signi-
ficant environmental problems and economical loss. The study of urease inhibi-
tion is of medical, agricultural and environmental significance. In the near past, a 
number of compounds have been proposed as urease inhibitors to reduce envi-
ronmental problems and enhance the uptake of urea nitrogen by plants.10,11 
Recently, interest in finding antioxidants for foods, cosmetics and medicines 
has increased considerably. Nowadays, antioxidants have become one of the ma-
jor areas of scientific research. Antioxidants have been extensively studied for 
their capacity to protect organisms and cells from damage induced by oxidative 
stress. Scientists in many different disciplines have become more interested in 
new compounds, either synthesized or obtained from natural sources, that could 
provide active components to prevent or reduce the impact of oxidative stress on 
cells.12 Chemical compounds and endogenous metabolic processes in the human 
body or in food systems might produce highly reactive free radicals, especially 
oxygen-derived radicals, which are capable of oxidizing biomolecules, resulting 
in cell death and tissue damage. Presently, synthetic antioxidant such as butylated 
hydroxyanisole (BHA), butylated hydroxytoluene (BHT), propyl gallate (PG) 
and tertiary-butylhydroquinone (TBHQ) are the most commonly used antioxi-
dants. However, their uses have been limited as they may be responsible for liver 
damage and carcinogenesis.13,14 For these reasons, this problem has been over-
come by new synthetic or natural compounds. 
Hydroxy fatty acids are ubiquitous in nature and have been found as cons-
tituents of triacylglycerols, waxes, cerebrosides, and other lipids in plants, ani-
mals, insects and microorganisms.15–18 The hydroxy fatty acids mentioned in the 
literature are valuable starting compounds used in the preparation of numerous 
textile auxiliaries, detergents, dispersion and emulsion reagents19 and play an im-
portant role in cancer chemotherapy.20 Hydroxy fatty acids exhibit an antitu-
mor21,22 effect at neutral and acidic pH values in human lung cancer (A 549) 
cells.23 In the literature, there is no data on the anti-elastase, anti-urease and 
antioxidant activities of monohydroxyeicosanoic acid isomers. In this study, the 
anti-elastase, anti-urease and antioxidant activities of (3–13)-monohydroxyeico-
sanoic acid isomers were determined for the first time. 
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EXPERIMENTAL 
(3–13)-Hydroxyeicosanoic acids (Scheme 1) were synthesized with high purity by Celik 
et al.24,25. The elastase activity was examined using N-succinyl-Ala-Ala-Ala-p-nitroanilide 
(STANA) as a substrate and by the measuring the release of p-nitroaniline at 410 nm.26 
Urease inhibitory activity was determined according to van Slyke and Archilbald.27 The cup-
ric reducing antioxidant capacity of the monohydroxyeicosanoic acids was determined accord-
ing to the method described by Apak et al.28 
Scheme 1. Structure of the studied mo-
nohydroxyeicosanoic acid isomers; n: 
1, 2, 4, 5, 6, 7, 8, 9, 10, 11; m = 17 – n. 
RESULTS AND DISCUSSION 
Fatty acids with one hydroxyl group, called α-hydroxy and β-hydroxy fatty 
acids, are healing agents in cosmetic and clinical use against skin diseases.29 
Hydroxy acids, mainly α-hydroxy acids and polyhydroxy acids, remain timeless 
in their ability to modulate skin structure and performance, providing both clini-
cal and cosmetic benefits to skin. α-Hydroxy acids (AHAs) are a class of com-
pounds derived from food sources that have become increasingly popular as skin 
rejuvenating agents. At higher concentrations (50–70 %), AHAs are used for su-
perficial skin peeling, while at low concentrations (8–30 %), they have been re-
ported to act as moisturizing agents and can cause a decrease in corneocytic at-
tachment.30,31 β-Hydroxy fatty acids are formed during mitochondrial β-oxida-
tion of fatty acids in mammalian tissues. Increased concentrations of free 3-OH 
fatty acids in body fluids are indicative of disorders in fatty acid oxidation, which 
is important for tissues with a high-energy demand.32  
According to a literature survey, no positional fatty acid isomers have been 
examined to date for their elastase inhibition. This work demonstrates the impor-
tance of the positional effect on elastase inhibition. The elastase inhibition acti-
vities of the monohydroxy C20 acids are given in Table I. The elastase inhibitory 
activities of monohydroxy C20 acids were found to increase in a dose dependent 
manner, the results are expressed as half maximal inhibitory concentrations 
(IC50) values, calculated from the regression equations prepared from the con-
centrations of samples. Amongst them, the best inhibition was found for the 10-
hydroxyeicosanoic acid, followed by the 11- and 9-hydroxyeicosanoic acid iso-
mers as seen in Table I. A higher elastase inhibitor activity is associated with a 
lower IC50 value. A high elastase inhibition (55.08±0.95 %) was seen at 1 µg 
mL–1 for the 10-hydroxy C20 acid and the IC50 value was 0.59±0.004 µg mL–1. 
A low elastase inhibition (24.28±0.63 %) was seen at 1 µg mL–1 for the 12-hyd-
roxy C20 acid and IC50 value of the 12-hydroxy C20 acid was 7.69±1.77 µg mL–1. 
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The (3–13)-hydroxyeicosanoic acid isomers showed good elastase inhibition. 
The 3-, 4-, 6-, 7-, 8-, 9-, 11- and 13-monohydroxy C20 acids showed nearly the 
same inhibition (Table I). 
TABLE I. The inhibition  of elastase activity (mean±SD) by the monohydroxyeicosanoic acid 
isomers at a concentration of 1 µg mL-1 
Hydroxyl position  Inhibition, %  IC50 / µg mL-1 
3 48.94±1.80  1.24±0.42 
4 48.47±0.73  1.43±0.33 
6 48.72±0.51  1.19±0.10 
7 44.84±0.39  2.10±0.04 
8 45.35±1.87  1.42±0.29 
9 49.41±1.00  1.08±0.18 
10 55.08±0.95  0.59±0.004 
11 51.04±0.37  0.88±0.02 
12 24.28±0.63  7.69±1.77 
13 26.84±2.79  4.9±2.19 
Elastase has a serine residue with a free hydroxyl group in its active center. 
This hydroxyl group may form an ester bond with the carboxyl group of the 
hydroxyeicosanoic acid isomers. In a previous study, lactones and their deriva-
tives were used as elastase inhibitors.33,34 This inhibition was explained by a 
new transesterification between the hydroxyl group of the serine and carboxyl 
group of the lactone ring. In the present study, some hydroxyeicosanoic acid iso-
mers were examined for their elastase inhibition activity (Table I). The hydroxyl 
and carboxyl groups of these isomers may be effective in the inhibition of elas-
tase. The carboxyl group may be more active than the hydroxyl group according 
to the literature data on the elastase inhibition activity of some saturated and 
unsaturated fatty acids.35,36 The inhibition effect of the hydroxyeicosanoic acid 
isomers may be explained by the formation of an ester bond between the carbo-
xyl group of the hydroxy acid isomers with the hydroxyl group of serine located 
in the active center. However, the experimental results obtained in this study 
showed that the position of the hydroxyl group of the hydroxy acid isomers plays 
a role on the inhibition effect indicating to a second effect resulting from an in-
teraction between the hydroxyl group of the hydroxy acid isomers and the hyd-
roxyl group of the serine. The best elastase inhibition was found for the 10-hyd-
roxy isomer. This isomer has a symmetrical structure and is like an arrow. The 
hydroxyl group of the 10-hydroxy isomer is not sterically hindered and is free. 
The other hydroxy acid isomers showed very similar inhibition, but their degree 
of inhibition was lower than that of the 10-hydroxy acid isomer. These isomers 
are less free and more sterically hindered than the 10-hydroxy acid isomer. The 
12- and 13-monohydroxy hydroxyeicosanoic acid isomers having the hydroxyl 
group closer to the end exerted the lowest inhibition. The molecule structure at 
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these positions may sterically prevent the formation of the hydrogen bridge 
between the hydroxyl groups of the serine and hydroxy acid isomers, affected 
probably by van der Waals forces. The hydroxyl group of the 12- and 13-hydroxy 
isomers is located very far from the carboxyl group. The hydroxyl group of the 
3–8 isomers is very close to the carboxyl group. Another effect depending on the 
position of the hydroxyl may occur between the hydroxyl and carboxyl group. 
This position effect may be also active on elastase inhibition effect of the hyd-
roxyeicosanoic acid isomers (Table I). 
Certain synthetic compounds have shown potential urease inhibition, such as 
hydroxyurea, flurofamide and hydroxyamic acid. However, the in vivo use of 
some of these is prohibited because of their toxicity or instability, for example, 
acetohydroxyamic acid was demonstrated to be teratogenic in rats.37 The disco-
very of potent and safe urease inhibitors is a very important area of pharmaceu-
tical research because of the involvement of urease in different pathological con-
ditions. 
The urease inhibition activity of the monohydroxy C20 acids is given in Table 
II. The urease activity was detected at a lower concentration of the hydroxy acid 
isomers than the elastase activity. Many synthetic and natural apple polyphenols 
have shown inhibitory activity against urease activity.38,39 Xiao et al. explained 
the urease inhibition activity of polyphenols by the ability of the hydroxyl group 
to form a complex with the nickel metal located at the active center of urease.38 
In this study, the urease inhibition activity of the monohydroxy C20 acid isomers 
was found to increase dose dependently. The results are expressed as IC50 values 
calculated from the regression equations prepared from the inhibition and the 
concentrations of the samples. A high urease inhibition (70.22±1.36 %) was seen 
at 0.1 µg mL–1 for the 8-hydroxy C20 acid. The IC50 value was 0.000012± 
±0.0000092 µg mL–1. A low urease inhibition (52.89±2.41 %) was seen at 0.1 µg 
mL–1 for the 6-hydroxy C20 acid. The IC50 value of the 6-hydroxy C20 acid was 
0.0766±0.01 µg mL–1. A number of novel synthetic and natural inhibitors of 
urease were investigated.40,41 Lodhi et al. studied triacontanyl palmitate as an 
effective inhibitor of urease.42 The 8-, 10- and 7-hydroxy C20 acid isomers, with 
the hydroxyl group located in the middle and close to the middle of the chain 
showed the best inhibition activities. These middle positions make these isomers 
successful in chelating and, as a result, in the urease inhibition. Moving away 
from these positions, the urease inhibitory activity decreased due to the molecule 
symmetry and steric hindrance of the alkyl groups. The activity against urease is 
the complex building ability of the hydroxyl group with nickel metal.37 The 
urease inhibition activity of the hydroxy acid isomers in this study can also be 
attributed to the complex building ability of the hydroxy acid isomers with nickel 
active center of the urease. The presence of –OH and –COOH group of mono-
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hydroxyeicosanoic acid isomers in this study may play together a great role in the 
inhibition of urease activity. 
TABLE II. The inhibition of urease activity (mean±SD) by the monohydroxyeicosanoic acid 
isomers at a concentration of 1 µg mL-1 
Hydroxyl position  Inhibition, % IC50 / µg mL-1 
3 59.18±0.64  0.0509±0.007 
4 66.32±0.50  0.0174±0.0002 
6 52.89±2.41  0.0766±0.01 
7 67.41±2.00  0.0065±0.0038 
8 70.22±1.36  0.000012±0.0000092 
9 64.85±1.27  0.0297±0.00028 
10 62.92±0.28  0.0049±0.0007 
11 67.87±2.62  0.0234±0.0043 
12 67.20±1.36  0.0301±0.000212 
13 60.21±1.46  0.0297±0.0031 
Antioxidants can be reductants, and deactiviation of oxidants by reductants 
can be described as redox reactions in which one reactions species is reduced at 
the expense of the oxidation of the other. As is known, transition metal ions, such 
as ferrous and cupric ions, accelerate lipid oxidation by breaking down hydrogen 
and lipid peroxides to reactive free radicals via the Fenton reaction.43 Therefore, 
chelating agents, known as secondary antioxidants, are important to retard radical 
degradation. There are several methods for the determination of antioxidant acti-
vities. In this study, the cupric reduction antioxidant capacity test (CUPRAC me-
thod) was used.28 The CUPRAC method is also used to determine the reducing 
power of antioxidant compounds.28 This method is based on the reduction of 
Cu2+ to Cu+ by antioxidants in the presence of neocuprein.44 In this method, a 
higher absorbance indicates a higher cupric ion reduction ability. The CUPRAC 
method is simultaneously cost effective, rapid, stable, selective and suitable for a 
variety of antioxidants regardless of the chemical type or hydrophilicity.45 The 
reducing capacity of a compound may serve as a significant indicator of its po-
tential antioxidant activity.44 
The cupric ion (Cu2+) reducing abilities of the monohydroxyeicosanoic acid 
isomers are given in Table III. The compounds 12-, 9-, 6- and 13-monohydroxy-
eicosanoic acid showed the lowest cupric ions (Cu2+) reducing capability (Table 
III). Compounds, 3-, 4-, 7-, 10- and 11-monohydroxyeicosanoic acids exhibited a 
moderate reducing power. The highest reducing capacity was found for 8-mono-
hydroxyeicosanoic acid. All the monohydroxyeicosanoic acid isomers are less 
effective on cupric ions (Cu2+) reducing ability than BHT. This method is based 
on the chelating ability of the hydroxyl group of some 3–13-monohydroxyeico-
sanoic acid isomers with Cu2+. The position of the hydroxyl group is important 
for the chelating activity. The best reducing activity was found for the 8-hydroxy 
_______________________________________________________________________________________________________________________
2012 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/  ENZYME INHIBITIONS AND ANTIOXIDANT ACTIVITY OF MONOHYDROXY EICOSANOIC ACID  1359 
isomer, in which the hydroxyl is located close to the middle of the chain. This 
position has no steric hindrance; therefore, the hydroxyl group is free and 
suitable for chelating with Cu2+. This reducing effect decreased with 3–7- and 9–
13-monohydroxyeicosanoic acid isomers because of the moleculear symmetry 
and steric hindrance of the alkyl groups. 
TABLE III. The cupric ions reducing antioxidant capacity of the monohydroxyeicosanoic acid 
isomers (mean±SD) at a concentration of 100 µg mL
-1 
Hydroxyl position  CUPRAC reducing power (absorbance)
 
3 0.35±0.008 
4 0.36±0.004 
6 0.23±0.004 
7 0.37±0.004 
8 0.57±0.006 
9 0.27±0.001 
10 0.37±0.002 
11 0.44±0.004 
12 0.32±0.002 
13 0.24±0.003 
BHT 1.65±0.045 
CONCLUSIONS 
A series of (3–13)-monohydroxyeicosanoic acid isomers were synthesized 
and their anti-elastase, anti-urease and antioxidant activities evaluated. The re-
sults showed that all the monohydroxyeicosanoic acid isomers exhibited anti-
elastase, anti-urease and antioxidant activities. According to the obtained results, 
the monohydroxyeicosanoic acid isomers with the hydroxyl group located in the 
middle or close to the middle of the chain showed higher antioxidant, anti-urease 
and anti-elastase activities than the other isomers. These monohydroxyeicosanoic 
acid isomers could be used in the agriculture, pharmacy and cosmetic industries 
due to their excellent anti-elastase, anti-urease and antioxidant activities. 
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Испитана је антиеластазна, антиуреазна и антиоксидативна активност групе (3–13)- 
-монохидроксилних  изомера  еикозанске  киселине.  Сва  анализирана  једињења  су  ис-
пољила све ове активности. Резултати су показали да највећу активност имају изомери 
код којих је хидроксилна група у средини или близу средине ланца. Према томе, (3–13)- 
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-монохидроксилни изомери еикозанске киселине, због својих својстава, могу наћи при-
мену у пољопривреди, фармацији и козметичкој индустрији. 
(Примљенo 5. јануара, ревидирано 5. априла 2012) 
REFERENCES 
1.  W. Bode, E. Meyer, J. C. Powers, Biochemistry 28 (1989) 1951 
2.  N. Tsuji, S. Moriwaki, Y. Suzuki, Y. Takema, G. Imokawa, Photochem. Photobiol. 74 
(2001) 283 
3.  S. Nenan, E. Boichot, V. Lagente, C. P. Bertrand, Mem. Inst. Oswaldo Cruz 100 (2005) 
167 
4.  B. Siedle, A. Hrenn, I. Merfort, Planta Med. 73 (2007) 401 
5.  L. Robert, Cosmet. Toiletries 116 (2001) 61 
6.  O. Wiedow, J. M. Schroder, H. Gregory, J. A. Young, E. Christophers, J. Biol. Chem. 265 
(1990) 14791 
7.  B. Krajewska, Wiad. Chem. 56 (2002) 223 
8.  H.L.T. Mobley, M. D. Island, R. P. Hausinger, Microbiol. Rev. 59 (1995) 451 
9.  H. L. T. Mobley, R, P. Hausinger, Microbiol. Rev. 53 (1989) 85 
10.  G.W. McCarty, J. M. Bremner, J. S. Lee, Plant Soil 127 (1990) 269 
11.  K. M. Khan, A. Wadood, M. Ali, Zia-Ullah, Z. Ul-Haq, M. A. Lodhi, J. Mol. Graphics 
Modell. 28 (2010) 792 
12.  H. H. Hussain, G. Babic, T. Durst, J. Wright, M. Flueraru, A. Chichirau, J. Org. Chem. 68 
(2003) 7023 
13.  H. P. Grice, Food Chem. Toxicol. 26 (1988) 717 
14.  H. C. Wichi, Food Chem. Toxicol. 24 (1986) 1127 
15.  E. Jantzen, A. Sonesson, T. Tangen, J. Eng, J. Clin. Microbiol. 31 (1993) 1413 
16.  I. I. Deridovich, O. V. Reunova, Comp. Biochem. Physiol., A 104 (1993) 23 
17.  N. Murakami, H. Shirahashi, J. Nagatsu, J. Sakakibara, Lipids 27 (1992) 776 
18.  V. M. Dembitsky, T. Rezanka, E. E. Shubina, Phytochemistry 34 (1993) 1057 
19.  R. T. Holman, W. D. Lundberg, T. Malkin, Prog. Chem. Fats Other Lipids 3 (1955)243 
20.  G. F. Townsend, W. H. Brown, Can. J. Biochem. Physiol. 39 (1961) 1765 
21.  S. Tolnai, J. F. Morgan, Can. J. Biochem. Physiol. 40 (1962) 1367 
22.  Y. Hayashi, Y. Nishikawa, H. Mori, H. Tamura, Y. I. Matsushita, T. Matsui, J. Ferment. 
Bioeng. 86 (1998) 149 
23.  V. Llado, S. Teres, M. Higuera, R. Alvarez, M. A. Noguera-Salva, J. E. Halver, Proc. 
Natl. Acad. Sci. U.S.A. 106 (2009) 13754 
24.  H. Celik, J. Serb. Chem. Soc. 67 (2002) 473 
25.  H. Celik, S. Ozeris, Chim. Acta Turc. 24 (1996) 23 
26.  A. E. James, D. W. Timothy, L. Gordon, Biochemistry 35 (1996) 9090 
27.  D. D. van Slyke, R. M. Archibald, J. Biol. Chem. 154 (1944) 623 
28.  R. Apak, K. Güçlü, M. Ozyürek, S. E. Karademir, E. Erçağ, Int. J. Food Sci. Nutr. 57 
(2006) 292 
29.  B. A. Green, R. J. Yu, E. J. van Scot, Clin. Dermatol. 27 (2009) 495 
30.  J. C. DiNardo, G. L. Grove, L. S. Moy, Dermatol. Surg. 22 (1996) 421 
31.  F. F. Becker, F. P. Langford, M. G. Rubin, P. Speelman, Dermatol. Surg. 22 (1996) 463 
32.  R. Jenske, W. Vetter, Food Chem. 114 (2009) 1122 
_______________________________________________________________________________________________________________________
2012 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/  ENZYME INHIBITIONS AND ANTIOXIDANT ACTIVITY OF MONOHYDROXY EICOSANOIC ACID  1361 
33.  B. Siedle, L. Gustavsson, S. Johansson, R. Murillo, V. Castro, L. Bohlin, I. Merfort, 
Biochem. Pharmacol. 65 (2003) 897 
34.  D. Dou, G. He, Y. Li, Z. Lai, L. Wei, K. R. Alliston, G. H. Lushington, D. M. Eichhorn, 
W. C. Groutas, Bioorg. Med. Chem. 18 (2010) 1093 
35.  B. Rennert, M. F. Melzig, Planta Med. 68 (2002) 767 
36.  G. Moroy, E. Bourquet, M. Decarme, J. Sapi, A. J. P. Alix, W. Hornebeck, S. Lorimier, 
Biochem. Pharmacol. 81 (2011) 626 
37.  Z. P. Xiao, D. H. Shi, H. Q. Li, L. N. Zhang, C. Xu, H. L. Zhu, Bioorg. Med. Chem. 15 
(2007) 3703 
38.  Z. P. Xiao, T. W. Ma, X. C. Peng, A. H. Zhang, H. L. Zhu, Eur. J. Med. Chem. 45 (2010) 
5064 
39.  E. Pastene, M. Troncoso, G. Figueroa, J. Alarcon, H. Speisky, J. Agric. Food Chem. 57 
(2009) 416 
40.  Z. Amtul, A. Rahman, R. A. Siddiqui, M. I. Choudhary, Curr. Med. Chem. 9 (2002) 1323 
41.  Z. Amtul, M. Rasheed, M. I. Choudhary, S. Rosanna, K. M. Khan, A. Rahman, Biochem. 
Biophys. Res. Commun. 319 (2004) 1053 
42.  M. A. Lodhi, M. A. Abbasi, M. I. Choudhart, V. U. Ahmad, Nat. Prod. Res. 21 (2007) 
721 
43.  B. Halliwell, J. M. C. Gutteridge, Biochem. J. 219 (1984) 1  
44.  Y. Çetinkaya, H. Göçer, A. Menzek, İ. Gülçin, Arch. Pharm. Chem. Life Sci. (2011) 1  
45.  E. Köksal, I. Gülçin, S. Beyza, O. Sarıkaya, E. Bursal, J. Enzyme Inhib. Med. Chem. 24 
(2009) 395. 
_______________________________________________________________________________________________________________________
2012 Copyright (CC) SCS
Available online at www.shd.org.rs/JSCS/